Trial
NCT06083675
Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Novo Nordisk A/S
Collaborators
—
Condition
Diabetes Mellitus, Type 2
Intervention
Semaglutide
Why stopped
Due to internal reprioritization, trial was cancelled.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-26